Sustained release of recombinant human insulin-like growth factor-I for treatment of diabetes

Journal of Controlled Release

Volumn 67, Issue 2-3, 2000, Pages 281-292

  Lam, Xanthe M ^a   Duenas, Eileen T ^a   Daugherty, Ann L ^a   Levin, Nancy ^a   Cleland, Jeffrey L ^a  

^a GENENTECH INC   (United States)

Author keywords

Diabetes; In vitro release; In vivo release; Microspheres; Polylactic co glycolic acid (PLGA); Recombinant human insulin like growth factor

Indexed keywords

POLYGLACTIN; RECOMBINANT SOMATOMEDIN C; ZINC CARBONATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DRUG BLOOD LEVEL; DRUG MANUFACTURE; FEMALE; FREEZE DRYING; IMMUNOASSAY; IN VITRO STUDY; INSULIN RESISTANCE; MICROENCAPSULATION; MOLECULAR WEIGHT; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN SECRETION; SUSTAINED RELEASE PREPARATION;

ANIMALS; CARBONATES; DELAYED-ACTION PREPARATIONS; DIABETES MELLITUS; DRUG COMPOUNDING; FEMALE; INSULIN-LIKE GROWTH FACTOR I; LACTIC ACID; MICROSCOPY, ELECTRON, SCANNING; MICROSPHERES; POLYGLYCOLIC ACID; POLYMERS; RATS; RATS, SPRAGUE-DAWLEY; RATS, ZUCKER; RECOMBINANT PROTEINS; ZINC COMPOUNDS;

EID: 0034601108     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-3659(00)00224-8     Document Type: Article

References (25)

1. Rinderknecht E., Humbel R.E. The amino acid sequence of human insulin-like growth factor I and its structural homology with proinsulin. J. Biol. Chem. 253:1978;2769-2776.
2. Daughaday W.H., Rotwein P. Insulin-like growth factors I and II. Peptide, messenger ribonucleic acid and gene structures, serum, and tissue concentrations. Endocr. Rev. 10:1989;68-91.
3. Salmon W.D., Daughaday W.H. A hormonally controlled serum factor which stimulates sulfate incorporation by cartilage in vitro. J. Lab. Clin. Med. 49:1957;825-836.
4. Schelechter N.L., Russell S.M., Spencer E.M., Nicoll C.S. Evidence suggesting that the direct growth-promoting effect of growth hormone on cartilage in vivo is mediated by local production of somatomedin. Proc. Natl. Acad. Sci. 83:1986;7932-7934.
5. Schoenle E.J., Zenobi P.D., Torresani T., Werder E.A., Zachmann M., Froesch E.R. Recombinant human insulin-like growth factor I (rhIGF I) reduces hyperglycemia in patients with extreme insulin resistance. Diabetologia. 34:1991;675-679.
6. Usala A.L., Madigan T., Burguers B., Sinha M.K., Caro J.F., Cunningham P., et al. Treatment of insulin-resistant diabetic ketoacidosis with insulin-like growth factor I in an adolescent with insulin-dependent diabetes mellitus. N. Engl. J. Med. 327:1992;853-857.
7. Morrow L.A., O'Brien M.B., Moller D.E. Recombinant human insulin-like growth factor-I therapy improves glycemic control and insulin action in the Type A syndrome of severe insulin resistance. J. Clin. Endocrinol. Metab. 79:1994;205-210.
8. Zenobi P.D., Jaeggi-Groisman S.E., Riesen W.F., Roder M.E., Froesch E.R. Insulin-like growth factor-I improves glucose and lipid metabolism in Type 2 diabetes mellitus. J. Clin. Invest. 90:1992;2234-2241.
9. Schalch D.S., Turman N.J., Marcsisin V.S., Heffernan M., Guler H.P. Short-term effects of recombinant human insulin-like growth factor I on metabolic control of patients with Type II diabetes mellitus. J. Clin. Endocrinol. Metab. 77:(6):1993;1563-1568.
10. Moses A.C., Young S.C.J., Morrow L.A., O'Brien M., Clemmons D.R. Recombinant human insulin-like growth factor I increases insulin sensitivity and improves glycemic control in Type II diabetes. Diabetes. 45:1996;91-100.
11. Johnson O.L., Cleland J.L., Lee H.J., Charnis M., Duenas E., Jaworowicz W., Shepard D., Shahzamani A., Jones A.J.S., Putney S.D. A month-long effect from a single injection of microencapsulated human growth hormone. Nat. Med. 2:1996;795-779.
12. Yasuda K. Sustained release formulation of interferon. Biomed. Ther. 27:(10):1993;1221-1223.
13. Yang J., Cleland J.L. Factors affecting the in vitro release of recombinant human interferon-γ (rhIFN-γ) from PLGA microspheres. J. Pharm. Sci. 86:1997;908-914.
14. Hora M.S., Rana R.K., Nunberg J.H., Gilly T.R., Hudson M.E. Controlled release of interleukin-2 from biodegradable microspheres. Biol. Technol. 8:1990;755-758.
15. Cleland J.L., Lim A., Barron L., Duenas E.T., Powell M.F. Development of a single shot subunit vaccine for HIV-1: Part 4. Optimizing microencapsulation and pulsatile release of MN rgp120 from biodegradable microspheres. J. Control. Rel. 47:1997;135-150.
16. Lewis D.D. Controlled release of bioactive agents from lactide/glycolide polymer. Chasin M., Langer R. Biodegradable Polymers as Drug Delivery Systems. 1990;1-41 Marcel Dekker, New York.
17. W. Gombotz, M. Healy, L. Brown, US Patent 5019400 (1991).
18. Cleland J.L. Powell M.F., Newman M. Vaccine Design: The Subunit Approach. 1995;439-472 Plenum Publishing, New York.
19. Cleland J.L., Jones A.J.S. Stable formulations of recombinant human growth hormone and interferon-γ for microencapsulation in biodegradable microspheres. Pharm. Res. 13:1996;1464-1475.
20. Johnson O.L., Jaworowicz W., Cleland J.L., Bailey L., Charnis M., Wu C., et al. The stabilization and encapsulation of human growth hormone into biodegradable microspheres. Pharm. Res. 14:1997;730-735.
21. Shanders L.M., Kell B.A., McRae G.I., Whitehead G.W. Prolonged controlled release of Naferlin, a luteinizing hormone-releasing hormone analogue, from biodegradable polymeric implants: influence of composition and molecular weight of polymer. J. Pharm. Sci. 75:1986;356-360.
22. Cleland J.L., Johnson O.L., Putney S.D., Jones A.J.S. Recombinant human growth hormone poly(lactic-coglycolic acid) microspheres formulation development. Adv. Drug Delivery Rev. 28:1997;71-84.
23. Cleland J.L., Duenas E.T., Daugherty A.L., Marian M., Yang J., Wilson M., et al. Recombinant human growth hormones poly(lactic-co-glycolic acid) (PLGA) microspheres provide a long lasting effect. J. Control. Rel. 49:1997;193-205.
24. Park T.G., Lu W., Crotts G. Importance of in vitro experimental conditions on protein release kinetics, stability and polymer degradation in protein encapsulated poly (D,L-lactic acid-co-glycolic acid) microspheres. J. Control. Rel. 33:1995;211-222.
25. Lam X.M., Duenas E.T., Cleland J.L. Microencapsulation of recombinant humanized monoclonal antibody for local delivery. Proc. Int. Symp. Control. Rel. Bioact. Mater. 24:1997;759-760.